Skip to main content
ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · IEX Real-Time Price · USD
0.169
+0.001 (0.30%)
Apr 25, 2024, 9:41 AM EDT - Market open

ReShape Lifesciences Market Cap

ReShape Lifesciences has a market cap or net worth of $4.08 million as of April 25, 2024. Its market cap has decreased by -50.23% in one year.

Market Cap
4.08M
Enterprise Value
-353.86K
1-Year Change
-50.23%
Ranking
#5482
Category
Nano-Cap
Stock Price
$0.17

Market Cap Chart

Since October 6, 2016, ReShape Lifesciences's market cap has decreased from $239.30M to $4.08M, a decrease of -98.29%. That is a compound annual growth rate of -41.67%.

History

DateMarket Cap% Change
Apr 24, 20243.90M-2.50%
Apr 23, 20244.00M2.56%
Apr 22, 20243.90M-
Apr 19, 20243.90M-2.50%
Apr 18, 20244.00M5.26%
Apr 17, 20243.80M-
Apr 16, 20243.80M-
Apr 15, 20243.80M-2.56%
Apr 12, 20243.90M2.63%
Apr 11, 20243.80M-2.56%
Apr 10, 20243.90M-4.88%
Apr 9, 20244.10M5.13%
Apr 8, 20243.90M-
Apr 5, 20243.90M-2.50%
Apr 4, 20244.00M-2.44%
Apr 3, 20244.10M2.50%
Apr 2, 20244.00M5.26%
Apr 1, 20243.80M58.33%
Mar 28, 20242.40M-
Mar 27, 20242.40M-
Mar 26, 20242.40M-4.00%
Mar 25, 20242.50M4.17%
Mar 22, 20242.40M4.35%
Mar 21, 20242.30M-
Mar 20, 20242.30M9.52%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Seelos Therapeutics 4.12M
Applied DNA Sciences 4.05M
Soligenix 4.03M
Aethlon Medical 4.01M
IMAC Holdings 4.00M
Clearmind Medicine 3.84M
Evoke Pharma 3.79M
Virpax Pharmaceuticals 3.71M
Market Cap Rankings